Long-lasting cholesterol lowering seen with Medicines Co drug: study

NEW ORLEANS (Reuters) - A new type of heart drug developed by Medicines Co significantly lowered "bad" LDL cholesterol in high-risk patients with no major safety issues, according to data from a midstage trial that helped the company identify the dose it will move into advanced testing.